Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy

Immune-oncologic (IO) therapy has revolutionized the treatment and management of oncologic disease. Immunotherapy functions by enhancing the host immune-systems ability to endogenously clear malignant cells, however, this activation can also lead to immune-mediated damage to healthy native tissues....

Descripción completa

Detalles Bibliográficos
Autores principales: Olsen, T. Anders, Zhuang, Tony Zibo, Caulfield, Sarah, Martini, Dylan J., Brown, Jacqueline T., Carthon, Bradley C., Kucuk, Omer, Harris, Wayne, Bilen, Mehmet Asim, Nazha, Bassel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982145/
https://www.ncbi.nlm.nih.gov/pubmed/35392134
http://dx.doi.org/10.3389/fendo.2022.779915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982145/
https://www.ncbi.nlm.nih.gov/pubmed/35392134
http://dx.doi.org/10.3389/fendo.2022.779915

Ejemplares similares